Erythrocytic α-Synuclein in Parkinson's Disease and Progressive Supranuclear Palsy-A Pilot Study

被引:3
作者
Cristiani, Costanza Maria [1 ]
Scaramuzzino, Luana [1 ]
Parrotta, Elvira Immacolata [2 ]
Cuda, Giovanni [3 ]
Quattrone, Aldo [1 ]
Quattrone, Andrea [1 ,4 ]
机构
[1] Magna Graecia Univ Catanzaro, Neurosci Res Ctr, Dept Med & Surg Sci, I-88100 Catanzaro, Italy
[2] Magna Graecia Univ Catanzaro, Inst Mol Biol, Dept Med & Surg Sci, I-88100 Catanzaro, Italy
[3] Magna Graecia Univ Catanzaro, Res Ctr Adv Biochem & Mol Biol, Dept Clin & Expt Med, I-88100 Catanzaro, Italy
[4] Magna Graecia Univ Catanzaro, Inst Neurol, Dept Med & Surg Sci, I-88100 Catanzaro, Italy
关键词
Parkinson's disease; progressive supranuclear palsy; alpha-synuclein; oligomeric alpha-synuclein; phosphorylated alpha-synuclein; red blood cells; RED-BLOOD-CELLS; POTENTIAL BIOMARKER; CEREBROSPINAL-FLUID; OLIGOMERS;
D O I
10.3390/biomedicines12112510
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background/Objectives: The current research examines the accuracy of alpha-synuclein in RBCs as a diagnostic biomarker for PD and PSP, despite their distinct molecular etiologies. Methods: We used ELISA to measure total, oligomeric, and p129-alpha-synuclein levels in erythrocytes from 8 PSP patients, 19 PD patients, and 18 healthy controls (HCs). The classification performances of RBC alpha-synuclein levels were investigated by receiver operator characteristic (ROC) curve. We also evaluated a possible correlation between RBC alpha-synuclein level and the biological and clinical features of our cohorts. Results: RBC total alpha-synuclein was higher in PSP patients compared to both PD patients and HCs, achieving good classification performance (AUC: 0.853) in distinguishing PSP patients from PD patients, with a sensitivity of 100% and a specificity of 70.6%; moreover, the levels of this biomarker positively correlated with disease severity in PSP group. Regarding oligomeric alpha-synuclein and p129-alpha-synuclein, the latter was slightly increased in RBCs from PSP patients compared to HCs, but no correlations were detected. Conclusions: Although these findings need to be confirmed in larger studies, our pilot work suggests that RBC total alpha-synuclein may represent a potential molecular biomarker for the differential diagnosis and clinical staging of PSP.
引用
收藏
页数:10
相关论文
共 52 条
[21]   Clinical Diagnosis of Progressive Supranuclear Palsy: The Movement Disorder Society Criteria [J].
Hoeglinger, Guenter U. ;
Respondek, Gesine ;
Stamelou, Maria ;
Kurz, Carolin ;
Josephs, Keith A. ;
Lang, Anthony E. ;
Mollenhauer, Brit ;
Mueller, Ulrich ;
Nilsson, Christer ;
Whitwell, Jennifer L. ;
Arzberger, Thomas ;
Englund, Elisabet ;
Gelpi, Ellen ;
Giese, Armin ;
Irwin, David J. ;
Meissner, Wassilios G. ;
Pantelyat, Alexander ;
Rajput, Alex ;
van Swieten, John C. ;
Troakes, Claire ;
Antonini, Angelo ;
Bhatia, Kailash P. ;
Bordelon, Yvette ;
Compta, Yaroslau ;
Corvol, Jean-Christophe ;
Colosimo, Carlo ;
Dickson, Dennis W. ;
Dodel, Richard ;
Ferguson, Leslie ;
Grossman, Murray ;
Kassubek, Jan ;
Krismer, Florian ;
Levin, Johannes ;
Lorenzl, Stefan ;
Morris, Huw R. ;
Nestor, Peter ;
Oertel, Wolfgang H. ;
Poewe, Werner ;
Rabinovici, Gil ;
Rowe, James B. ;
Schellenberg, Gerard D. ;
Seppi, Klaus ;
van Eimeren, Thilo ;
Wenning, Gregor K. ;
Boxer, Adam L. ;
Golbe, Lawrence I. ;
Litvan, Irene .
MOVEMENT DISORDERS, 2017, 32 (06) :853-864
[22]   Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies [J].
Kawahata, Ichiro ;
Finkelstein, David, I ;
Fukunaga, Kohji .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (11)
[23]   Neurofilaments as biomarkers in neurological disorders - towards clinical application [J].
Khalil, Michael ;
Teunissen, Charlotte E. ;
Lehmann, Sylvain ;
Otto, Markus ;
Piehl, Fredrik ;
Ziemssen, Tjalf ;
Bittner, Stefan ;
Sormani, Maria Pia ;
Gattringer, Thomas ;
Abu-Rumeileh, Samir ;
Thebault, Simon ;
Abdelhak, Ahmed ;
Green, Ari ;
Benkert, Pascal ;
Kappos, Ludwig ;
Comabella, Manuel ;
Tumani, Hayrettin ;
Freedman, Mark S. ;
Petzold, Axel ;
Blennow, Kaj ;
Zetterberg, Henrik ;
Leppert, David ;
Kuhle, Jens .
NATURE REVIEWS NEUROLOGY, 2024, 20 (05) :269-287
[24]   Integrated 18F-T807 Tau PET, Structural MRI, and Plasma Tau in Tauopathy Neurodegenerative Disorders [J].
Li, Cheng-Hsuan ;
Chen, Ta-Fu ;
Chiu, Ming-Jang ;
Yen, Ruoh-Fang ;
Shih, Ming-Chieh ;
Lin, Chin-Hsien .
FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
[25]   A Panel of Plasma Biomarkers for Differential Diagnosis of Parkinsonian Syndromes [J].
Li, Qi ;
Li, Zhen ;
Han, Xiaoxuan ;
Shen, Xiao ;
Wang, Fei ;
Bai, Lipeng ;
Li, Zhuo ;
Zhang, Rui ;
Wang, Yanlin ;
Zhu, Xiaodong .
FRONTIERS IN NEUROSCIENCE, 2022, 16
[26]   Receptor-Dependent Endocytosis Mediates α-Synuclein Oligomer Transport Into Red Blood Cells [J].
Li, Wei ;
Hu, Junya ;
Li, Xin ;
Lu, Zhe ;
Li, Xuying ;
Wang, Chaodong ;
Yu, Shun .
FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
[27]   Alterations of Erythrocytic Phosphorylated Alpha-Synuclein in Different Subtypes and Stages of Parkinson's Disease [J].
Li, Xu-Ying ;
Li, Wei ;
Li, Xin ;
Li, Xu-Ran ;
Sun, Linjuan ;
Yang, Weiwei ;
Cai, Yanning ;
Chen, Zhigang ;
Wu, Jun ;
Wang, Chaodong ;
Yu, Shun .
FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
[28]   Plasma pS129-α-Synuclein Is a Surrogate Biofluid Marker of Motor Severity and Progression in Parkinson's Disease [J].
Lin, Chin-Hsien ;
Liu, Huei-Chun ;
Yang, Shieh-Yueh ;
Yang, Kai-Chien ;
Wu, Chau-Chung ;
Chiu, Ming-Jang .
JOURNAL OF CLINICAL MEDICINE, 2019, 8 (10)
[29]   Plasma Biomarkers Differentiate Parkinson's Disease From Atypical Parkinsonism Syndromes [J].
Lin, Chin-Hsien ;
Yang, Shieh-Yueh ;
Horng, Herng-Er ;
Yang, Che-Chuan ;
Chieh, Jen-Jie ;
Chen, Hsin-Hsien ;
Liu, Bing-Hsien ;
Chiu, Ming-Jang .
FRONTIERS IN AGING NEUROSCIENCE, 2018, 10
[30]   Erythrocytic alpha-synuclein in early Parkinson?s disease: A 3-year longitudinal study [J].
Liu, Genliang ;
Yu, Zhenwei ;
Gao, Liyan ;
Zheng, Yuanchu ;
Feng, Tao .
PARKINSONISM & RELATED DISORDERS, 2022, 104 :44-48